Focus On Execution Pays Off, Sets BMS Up For Growth In 2023

Sales Of Nine New Drugs Set To Double From 2022 Total

 
• By Mandy Jackson
  
two linear arrows up down icon
BMS expects to reverse its 2022 revenue decline with 2% growth in 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip